Gould Capital, LLC Bristol Myers Squibb CO Transaction History
Gould Capital, LLC
- $141 Million
- Q2 2024
A detailed history of Gould Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Gould Capital, LLC holds 100 shares of BMY stock, worth $4,913. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$4,913
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,400Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$9.17 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.79 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.49 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.67 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$2.9 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $104B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...